Related Experiment Video
Updated: Aug 14, 2026

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
A DNA-based cancer vaccine enhances lymphocyte cross talk by engaging the NKG2D receptor
He Zhou1, Yunping Luo, Charles D Kaplan
1Department of Immunology, The Scripps Research Institute, 10550 North Torrey Pines Rd, La Jolla, CA 92037, USA.
Abstract:
The NKG2D receptor is a stimulatory receptor expressed on NK cells and activated CD8 T cells. We previously demonstrated that engaging the NKG2D receptor markedly improved the efficacy of a survivin-based DNA vaccine. The combination vaccine, encoding both the NKG2D ligand H60 and survivin, activates innate and adaptive antitumor immunity and results in better protection against tumors of different origin and NKG2D expression levels. Here we demonstrate that the enhanced vaccine efficacy is in part attributable to increased cross talk between lymphocytes. Depletion of CD8 T cells during priming reduces the vaccine-induced activation of dendritic cells (DCs) and NK cell activity. Depletion of NK cells during priming leads to reduced DC activation and CTL activity. However, depletion of CD4 T cells results in the activation of DCs, NK cells, and CD8 T cells and enhances NK cell activity. The pH60/Survivin vaccine also increases DCs and NK cells but decreases CD4 T cell homing to Peyer patches, presumably as a result of changes in the homing receptor profile. Thus, by preferentially activating and attracting positive regulators and reducing negative regulators in Peyer patches, this dual-function DNA vaccine induces a microenvironment more suitable for NK cell activation and T cell priming.
Insights
This study shows a dual-function DNA vaccine enhances antitumor immunity by improving crosstalk between immune cells. It activates NK cells and CD8 T cells while reducing suppressive CD4 T cells for better tumor protection.
Area of Science:
- Immunology
- Vaccinology
- Cancer Research
Background:
- The NKG2D receptor is crucial for activating NK cells and CD8 T cells.
- Previous work showed NKG2D receptor engagement improves DNA vaccine efficacy.
- A combined vaccine encoding H60 and survivin enhances antitumor immunity.
Purpose of the Study:
- To investigate the mechanisms behind the enhanced efficacy of the pH60/Survivin DNA vaccine.
- To elucidate the roles of CD8 T cells, NK cells, and CD4 T cells in vaccine-induced antitumor immunity.
Main Methods:
- Utilizing a dual-function DNA vaccine encoding NKG2D ligand H60 and survivin.
- Employing lymphocyte depletion strategies (CD8 T cells, NK cells, CD4 T cells) during vaccine priming.
- Assessing immune cell activation (dendritic cells, NK cells, CD8 T cells, CD4 T cells) and homing patterns.
Main Results:
- Depletion of CD8 T cells or NK cells impaired vaccine-induced DC and lymphocyte activation.
- Depletion of CD4 T cells enhanced DC, NK cell, and CD8 T cell activation, alongside increased NK cell activity.
- The pH60/Survivin vaccine promoted DC and NK cell increases but decreased CD4 T cell homing to Peyer patches.
Conclusions:
- Enhanced vaccine efficacy is partly due to improved lymphocyte crosstalk.
- The vaccine modulates immune cell populations, favoring activation of antitumor effectors.
- The dual-function DNA vaccine creates a favorable microenvironment for NK cell activation and T cell priming, reducing negative regulators.
More Related Videos
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...